Paid Clinical Trials in South Dakota

Browse 236 Paid Studies South Dakota Across 1249 Cities
134 Phase 3 Trial · 14011 Paid Studies South Dakota Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Paid Clinical Trials in South Dakota

Reviewed by Michael Gill, B. Sc.

Image of California Dermatology & Clinical Research Institute in Encinitas, United States.

Phase-Based Progress Estimates

Plaque Psoriasis PF-07038124 0.06% Ointmentfor Dermatitis

The purpose of this clinical trial is to learn about how the safety, how well the study medicine works, extent to which side affects can be tolerated, and how the study medicine is changed and eliminated from your body after you apply it on your skin. The study medicine is in ointment form.

California Dermatology & Clinical Research Institute (+19 Sites)Pfizer CT.gov Call CenterPfizer

Image of Local Institution in Los Angeles, United States.

Phase-Based Progress Estimates

BMS-986406for Cancer, Advanced

This trial is testing a new drug to see if it is safe and works well when used alone or with another existing cancer drug.

Local Institution (+9 Sites)Bristol-Myers SquibbBristol-Myers Squibb

Image of Saint Joseph Heritage Medical Group in Santa Rosa, United States.

Phase-Based Progress Estimates

Tucatinibfor Colorectal Cancer

This trial is testing to see if tucatinib in combination with other drugs is more effective than standard of care drugs at treating participants with HER2 positive colorectal cancer.

Saint Joseph Heritage Medical Group (+27 Sites)James Ward, MDSeagen Inc.

Image of Sibley Memorial Hospital in Washington, United States.

Phase-Based Progress Estimates

Capecitabinefor Pancreas

This trial is testing two different chemotherapy drugs (capecitabine and temozolomide) against a radioactive drug (lutetium Lu 177 dotatate) to see which is more effective at killing pancreatic neuroendocrine tumor cells in patients with advanced disease.

Sibley Memorial Hospital (+65 Sites)Timothy J. b, MD

Image of Middlesex Hospital in Middletown, United States.

Phase-Based Progress Estimates

Palmidrolfor Chemotherapy Induced Peripheral Neuropathy (CIPN)

This trial is testing whether a drug called PEA can help relieve symptoms of chemotherapy-induced nerve damage. This nerve damage can cause pain, numbness, tingling, or muscle weakness, and PEA may help against these bothersome symptoms.

Middlesex Hospital (+9 Sites)Mellar P Davis

Image of Nature Coast Clinical Research in Crystal River, United States.

Phase-Based Progress Estimates

BRIMOCHOL™for Presbyopia

FDA Approved Drug

This trial will study the safety and efficacy of two drugs, BRIMOCHOL and Carbachol, in subjects with presbyopia.

FDA Approved Drug

Nature Coast Clinical Research (+41 Sites)

Image of Sarasota Memorial Hospital ( Site 0018) in Sarasota, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Carcinoma, Ovarian Epithelial

FDA Approved Drug

This trial is testing a new cancer treatment combining two drugs, pembrolizumab and paclitaxel, with or without bevacizumab. The goal is to see if this new combination can prolong the amount of time until the cancer progresses, compared to the current standard treatment.

FDA Approved Drug

Sarasota Memorial Hospital ( Site 0018) (+25 Sites)Medical DirectorMerck Sharp & Dohme Corp.

Image of Alta Bates Summit Medical Center-Herrick Campus in Berkeley, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IVA Lung Cancer AJCC v8

FDA Approved Drug

This trial is testing immunotherapy treatment with N-803 and pembrolizumab for advanced non-small cell lung cancer. N-803 may activate natural killer cells so that they can stimulate an immune response to help fight cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

FDA Approved Drug

Alta Bates Summit Medical Center-Herrick Campus (+99 Sites)John M Wrangle

Image of Kingman Regional Medical Center in Kingman, United States.

Phase-Based Progress Estimates

Olaparibfor Carcinoma

FDA Approved Drug

This trial is testing whether adding olaparib after surgery and chemo helps treat pancreatic cancer with a pathogenic mutation in BRCA1, BRCA2, or PALB2.

FDA Approved Drug

Kingman Regional Medical Center (+99 Sites)Kim A Reiss Binder

Image of NRG Oncology-Pittsburgh Center in Pittsburgh, United States.

Phase-Based Progress Estimates

Arm 2: No Breast Radiation Therapy + Endocrine Therapyfor Breast Cancer

FDA Approved Drug

This trial is testing whether a combination of surgery and hormone therapy is non-inferior to surgery, hormone therapy, and radiation for treating breast cancer.

FDA Approved Drug

NRG Oncology-Pittsburgh Center (+99 Sites)

Image of COAST Investigational Site in Phoenix, United States.

Phase-Based Progress Estimates

2.0 Afliberceptfor Age related macular degeneration

FDA Approved Drug

This trial will compare a new treatment to a sham (fake) treatment in order to see if the new treatment is effective. The primary efficacy will be determined at Week 52, meaning that's how long the trial will last.

FDA Approved Drug

COAST Investigational Site (+50 Sites)Opthea Limited

Image of Cancer Center at Saint Joseph's in Phoenix, United States.

Phase-Based Progress Estimates

Eribulin Mesylatefor Carcinoma

FDA Approved Drug

This trial is testing whether adding the drug eribulin to standard chemotherapy drugs may work better in treating patients with metastatic urothelial cancer.

FDA Approved Drug

Cancer Center at Saint Joseph's (+99 Sites)Sarmad Sadeghi

Image of Katmai Oncology Group in Anchorage, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Non-Small Cell Lung Carcinoma (NSCLC)

FDA Approved Drug

This trial is testing the addition of the immunotherapy drug pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB IIIA or IIIB non-small cell lung cancer.

FDA Approved Drug

Katmai Oncology Group (+99 Sites)Jacob M Sands

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Radiation Therapyfor Cancer of Esophagus

FDA Approved Drug

This trial is studying how well adding radiotherapy to the usual chemotherapy treatment works compared to the usual treatment alone in treating patients with esophageal and gastric cancer.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Nataliya V Uboha

Image of Mayo Clinic Hospital in Arizona in Phoenix, United States.

Phase-Based Progress Estimates

Ipilimumabfor Glioblastoma

FDA Approved Drug

This trial is testing immunotherapy drugs to treat patients with recurrent glioma who have a high number of mutations. The drugs may help the body's immune system attack the cancer and lower the chance of the cancer growing or spreading.

FDA Approved Drug

Mayo Clinic Hospital in Arizona (+99 Sites)Gavin P Dunn

Image of Central Research Associates Inc in Birmingham, United States.

Phase-Based Progress Estimates

MRNA-1653for Parainfluenza

Waitlist Available

This trial will study whether a new vaccine is safe and effective in adults and children.

Waitlist Available

Central Research Associates Inc (+19 Sites)ModernaTX, Inc.

Image of University of South Alabama Mitchell Cancer Institute in Mobile, United States.

Phase-Based Progress Estimates

Ramucirumabfor Non-Small Cell Lung Carcinoma

Waitlist Available

FDA Approved Drug

This trial is studying ramucirumab and pembrolizumab to see how well they work compared to standard of care in treating patients with non-small cell lung cancer.

Waitlist Available

FDA Approved Drug

University of South Alabama Mitchell Cancer Institute (+99 Sites)Karen L Reckamp

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IIIB Uterine Corpus Cancer AJCC v8

FDA Approved Drug

This trial is studying the combination of pembrolizumab, paclitaxel, and carboplatin to treat endometrial cancer.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Ramez N Eskander

Image of University of California Davis Comprehensive Cancer Center ( Site 0005) in Sacramento, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Glioblastoma

Waitlist Available

FDA Approved Drug

This trial will test a combination of two drugs to see if it is safe and effective for treating various types of cancer.

Waitlist Available

FDA Approved Drug

University of California Davis Comprehensive Cancer Center ( Site 0005) (+15 Sites)Medical DirectorMerck Sharp & Dohme LLC

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IIIB Lung Cancer AJCC v8

FDA Approved Drug

This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Hossein Borghaei

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Cisplatinfor Intrahepatic Cholangiocarcinoma

Waitlist Available

FDA Approved Drug

This trial is studying gemcitabine hydrochloride, cisplatin, and nab-paclitaxel to see how well they work in treating patients with biliary tract cancer.

Waitlist Available

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Rachna Shroff

Image of University of Arizona Cancer Center ( Site 0018) in Tucson, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Tumors, Solid

FDA Approved Drug

This trial will evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based parent studies who roll-over into this extension study.

FDA Approved Drug

University of Arizona Cancer Center ( Site 0018) (+51 Sites)Medical DirectorMerck Sharp & Dohme Corp.

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Autologous Hematopoietic Stem Cell Transplantationfor Ganglioneuroblastoma

FDA Approved Drug

This trial is testing a new drug, lorlatinib, in combination with the standard treatment for neuroblastoma or ganglioneuroblastoma, compared to the standard treatment alone.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Steven DuBois

Image of University of Arizona Cancer Center-Orange Grove Campus in Tucson, United States.

Phase-Based Progress Estimates

Cisplatinfor Stage III Lip and Oral Cavity Cancer AJCC v8

FDA Approved Drug

This trial is testing whether radiation therapy is more effective with or without cisplatin in treating patients with squamous cell carcinoma of the head and neck.

FDA Approved Drug

University of Arizona Cancer Center-Orange Grove Campus (+99 Sites)Robert Ferris

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Phase-Based Progress Estimates

Docetaxelfor Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7

FDA Approved Drug

This trial is testing how well radiation therapy works in combination with different drugs after surgery to treat patients with high-risk stage III-IV head and neck cancer.

FDA Approved Drug

University of Alabama at Birmingham Cancer Center (+99 Sites)Paul M Harari

25 Paid Studies South Dakota Near Me

Top Cities for Paid Studies South Dakota

Image of Anchorage in Alaska.

Anchorage

216Active Trials

Providence Alaska Medical CenterTop Active Site

Image of Los Angeles in California.

Los Angeles

202Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site